VEP has helped financier clients manage the strategic risks and opportunities of their planned investments or loans in a huge range of deal sizes and sectors (see Sector Experience).
We select below just a dozen or so recent examples (out of >125 since the mid-1980s) where Vaughan Evans has led assignments in strategic due diligence or strategic screening:
- For a U.K. venture capitalist, he led the team that assessed the business risks and opportunities of investing
in a British producer of air filters for use in gas turbines. The transaction was completed successfully
- For a European private equity house, he led the team that assessed the business risks and opportunities of acquiring the international airport ground-handling business of a European
airline. Despite 11 September and the liquidity difficulties of the vendor, the transaction was completed successfully
- For a European private equity house, he advised the team that assessed the business risks and opportunities of acquiring a large European plastics producer. The transaction was completed
successfully
- For an international investment bank lead arranging the project finance, he led the team that reviewed the business plan of a cable TV, telecommunications and data operator in Southern
Germany. The transaction was completed successfully
- For a European private equity house, he led the team that assessed the business risks and opportunities of acquiring a European producer of dental implants, crowns and other supplies.
The auction was lost to a trade buyer
- For a European private equity house, he led the team that assessed the business risks and opportunities of acquiring a leading European publisher of reference information and professional
journals. The vendor withdrew the business for sale
- For a UK venture capitalist, he led the team that screened the business risks and opportunities of investing in a telemarketing and call centre business positioned at the higher value added
end of the range. The client was advised to withdraw
- For a European private equity house, leading the team that assessed the business risks and opportunities of acquiring a leading European producer of blood plasma derivatives and other medical
supplies. The transaction was completed successfully
- For a European private equity house, leading the team that assessed the business risks and opportunities of taking private a leading Irish-based diversified packager (cartons, labels, flexible
and rigid plastics) and printer, operating in both Europe and the U.S. The transaction was completed successfully
- For a European private equity house, leading the team that assessed the business risks and opportunities of investing in the management buy-out of a Scottish-based pharmaceutical research
company, specialising in pre-clinical and Phase I trials. The transaction was completed successfully
- For a European private equity house, leading the team that assessed the business risks and opportunities of investing in the management buy-out of a leading U.K. night-club group. The
transaction was completed successfully
- For a European private equity house, assessing the business risks and opportunities of acquiring a U.S.-based producer of wear-resistant cobalt and nickel-based components and consumables from
plants in the U.S., the U.K. and Germany. The transaction was completed successfully
.